IT1275532B - Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa - Google Patents

Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa

Info

Publication number
IT1275532B
IT1275532B ITMI951513A ITMI951513A IT1275532B IT 1275532 B IT1275532 B IT 1275532B IT MI951513 A ITMI951513 A IT MI951513A IT MI951513 A ITMI951513 A IT MI951513A IT 1275532 B IT1275532 B IT 1275532B
Authority
IT
Italy
Prior art keywords
dihydropyridinic
therapy
prevention
derivatives
lercanidipine
Prior art date
Application number
ITMI951513A
Other languages
English (en)
Inventor
Abraham Sartani
Amedeo Leonardi
Rodolfo Testa
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of ITMI951513A0 publication Critical patent/ITMI951513A0/it
Priority to ITMI951513A priority Critical patent/IT1275532B/it
Priority to US08/645,964 priority patent/US5767136A/en
Priority to US08/645,963 priority patent/US5912351A/en
Priority to IL12230296A priority patent/IL122302A/xx
Priority to KR1019980700039A priority patent/KR19990028741A/ko
Priority to CA002219501A priority patent/CA2219501A1/en
Priority to ES96924834T priority patent/ES2138359T3/es
Priority to CZ98116A priority patent/CZ11698A3/cs
Priority to PCT/EP1996/002872 priority patent/WO1997003669A1/en
Priority to SK41-98A priority patent/SK4198A3/sk
Priority to CN96195439A priority patent/CN1190345A/zh
Priority to DE69603968T priority patent/DE69603968T2/de
Priority to DK96924834T priority patent/DK0839036T3/da
Priority to HU9802736A priority patent/HUP9802736A3/hu
Priority to JP9506222A priority patent/JPH11509214A/ja
Priority to EP96924834A priority patent/EP0839036B1/en
Priority to AT96924834T priority patent/ATE183644T1/de
Priority to AU65164/96A priority patent/AU690471B2/en
Priority to ZA965924A priority patent/ZA965924B/xx
Publication of ITMI951513A1 publication Critical patent/ITMI951513A1/it
Application granted granted Critical
Publication of IT1275532B publication Critical patent/IT1275532B/it
Priority to NO980171A priority patent/NO980171L/no
Priority to GR990402179T priority patent/GR3031096T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI951513A 1995-05-12 1995-07-14 Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa IT1275532B (it)

Priority Applications (21)

Application Number Priority Date Filing Date Title
ITMI951513A IT1275532B (it) 1995-07-14 1995-07-14 Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa
US08/645,964 US5767136A (en) 1995-05-12 1996-05-10 1,4-Dihydropyridines useful for prevention or reduction of atherosclerotic lesions on arterial walls
US08/645,963 US5912351A (en) 1995-05-12 1996-05-10 Anhydrous 1,4-Dihydropyridines and salts thereof
CN96195439A CN1190345A (zh) 1995-07-14 1996-06-28 1,4－二氢吡啶衍生物在预防和治疗动脉壁的动脉粥样硬化恶化中的用途
JP9506222A JPH11509214A (ja) 1995-07-14 1996-06-28 動脈壁のアテローム硬化性分解の予防および治療における１，４−ジヒドロピリジン誘導体の使用
CA002219501A CA2219501A1 (en) 1995-07-14 1996-06-28 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls
ES96924834T ES2138359T3 (es) 1995-07-14 1996-06-28 Utilizacion de derivados de 1,4 dihidropiridina en la prevencion y la terapia de la degradacion arteroesclerosa de las paredes arteriales.
CZ98116A CZ11698A3 (cs) 1995-07-14 1996-06-28 Použití 1,4-dihydropyridinových derivátů pro výrobu farmaceutického prostředku
PCT/EP1996/002872 WO1997003669A1 (en) 1995-07-14 1996-06-28 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls
SK41-98A SK4198A3 (en) 1995-07-14 1996-06-28 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls
IL12230296A IL122302A (en) 1995-07-14 1996-06-28 Use of 1,4-dihydropyridine derivatives in the preparation of a medicament for the prevention and therapy of atherosclerotic degradation of arterial walls and pharmaceutical compositions containing such derivatives
DE69603968T DE69603968T2 (de) 1995-07-14 1996-06-28 Verwendung von 1,4-dihydropyridinderivaten in der prävention und therapie der atherosklerotischen degeneration von arterienwänden
DK96924834T DK0839036T3 (da) 1995-07-14 1996-06-28 Anvendelse af 1,4-dihydropyridinderivater til forebyggelse og terapi af atherosklerotisk nedbrydning af arterievægge
HU9802736A HUP9802736A3 (en) 1995-07-14 1996-06-28 Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial walls
KR1019980700039A KR19990028741A (ko) 1995-07-14 1996-06-28 아테롬성 동맥경화증으로 인한 동맥벽의 파괴의 예방 및 치료에이용될 수 있는 1,4-디하이드로피리딘
EP96924834A EP0839036B1 (en) 1995-07-14 1996-06-28 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls
AT96924834T ATE183644T1 (de) 1995-07-14 1996-06-28 Verwendung von 1,4-dihydropyridinderivaten in der prävention und therapie der atherosklerotischen degeneration von arterienwänden
AU65164/96A AU690471B2 (en) 1995-07-14 1996-06-28 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls
ZA965924A ZA965924B (en) 1995-07-14 1996-07-12 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls
NO980171A NO980171L (no) 1995-07-14 1998-01-14 Anvendelse av 1,4-dihydropyridin-derivater ved forebyggelse av behandling av aterosklerotisk nedbrytning av arterie-vegger
GR990402179T GR3031096T3 (en) 1995-07-14 1999-08-26 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI951513A IT1275532B (it) 1995-07-14 1995-07-14 Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa

Publications (3)

Publication Number Publication Date
ITMI951513A0 ITMI951513A0 (it) 1995-07-14
ITMI951513A1 ITMI951513A1 (it) 1997-01-14
IT1275532B true IT1275532B (it) 1997-08-07

Family

ID=11371972

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI951513A IT1275532B (it) 1995-05-12 1995-07-14 Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa

Country Status (19)

Country Link
EP (1) EP0839036B1 (it)
JP (1) JPH11509214A (it)
KR (1) KR19990028741A (it)
CN (1) CN1190345A (it)
AT (1) ATE183644T1 (it)
AU (1) AU690471B2 (it)
CA (1) CA2219501A1 (it)
CZ (1) CZ11698A3 (it)
DE (1) DE69603968T2 (it)
DK (1) DK0839036T3 (it)
ES (1) ES2138359T3 (it)
GR (1) GR3031096T3 (it)
HU (1) HUP9802736A3 (it)
IL (1) IL122302A (it)
IT (1) IT1275532B (it)
NO (1) NO980171L (it)
SK (1) SK4198A3 (it)
WO (1) WO1997003669A1 (it)
ZA (1) ZA965924B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20011726A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US6852737B2 (en) 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
AR053023A1 (es) * 2005-02-25 2007-04-18 Recordati Ireland Ltd Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
NZ610465A (en) 2010-10-12 2015-05-29 Medicines Co Clevidipine emulsion formulations containing antimicrobial agents
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
EA023996B1 (ru) 2010-12-24 2016-08-31 КРКА, д.д., НОВО МЕСТО Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацевтически приемлемые соли совместно с органической кислотой

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters

Also Published As

Publication number Publication date
CA2219501A1 (en) 1997-02-06
AU690471B2 (en) 1998-04-23
HUP9802736A3 (en) 2000-03-28
ES2138359T3 (es) 2000-01-01
KR19990028741A (ko) 1999-04-15
ZA965924B (en) 1997-01-30
EP0839036B1 (en) 1999-08-25
GR3031096T3 (en) 1999-12-31
HUP9802736A2 (hu) 1999-03-29
DE69603968T2 (de) 2000-04-06
JPH11509214A (ja) 1999-08-17
AU6516496A (en) 1997-02-18
DE69603968D1 (de) 1999-09-30
IL122302A0 (en) 1998-04-05
CN1190345A (zh) 1998-08-12
NO980171D0 (no) 1998-01-14
ATE183644T1 (de) 1999-09-15
WO1997003669A1 (en) 1997-02-06
DK0839036T3 (da) 2000-01-24
IL122302A (en) 2000-08-13
ITMI951513A0 (it) 1995-07-14
SK4198A3 (en) 1998-05-06
NO980171L (no) 1998-01-14
EP0839036A1 (en) 1998-05-06
CZ11698A3 (cs) 1998-06-17
ITMI951513A1 (it) 1997-01-14

Similar Documents

Publication Publication Date Title
IT8803504A0 (it) Derivati eparinici e procedimento per la loro preparazione
IT8822399A0 (it) Derivati di monofosforil lipide a e procedimento per la loro preparazione.
NO975985L (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
DE69422163D1 (de) Glycerolderivat, vorrichtung und pharmazeutische zusammensetzung
FR2636532B1 (fr) Compositions pharmaceutiques
NO976128L (no) Forbindelser og farmasöytiske blandinger som inneholder dem
NO975984D0 (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
IT1275532B (it) Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa
NO975365L (no) Benzopyraner og farmasöytiske sammensetninger inneholdende dem
NO894594D0 (no) Farmasoeytiske sammensetninger omfattende labdan diterpenoid-derivater og pyrimido(6,1-a)isoquinolin-4-ono-derivater.
TW372962B (en) Pharmaceutical compositions for the prevention, arrest or reversal of atherosclerotic degradation in the arterial walls of a patient
IT1237509B (it) Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche
ITMI910846A0 (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
FR2725720B1 (fr) Derives metalloceniques du diarylethylene, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits derives
IT9021880A0 (it) Nuovi derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI932468A0 (it) Nuovi difenilimidazoli utili nel trattamento di dislipidemia, arteriosclerosi e malattie coronariche procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1284139B1 (it) Composizione farmaceutica comprendente un coenzima utile nel trattamento della sindrome da immunodeficenza acquisita
IT1284080B1 (it) Derivati ossaindenici e procedimento per la loro preparazione
ITMI951252A0 (it) Bicarbonati di derivati della 2,6-dimetilanilina loro uso in terapia e composizioni farmaceutiche che li comprendono
DE29501370U1 (de) Zerlegbares Schrankmöbel
IT1282376B1 (it) Derivati salini della cefalexina e loro composizioni farmaceutiche
EE9800323A (et) HIV proteaasi inhibiitorit VX 478 ja vees lahustuva vitamiin E derivaati vitamiin E-TPGSi sisaldavad preparaadid
ITMI911535A1 (it) Derivati di una pirrolo-piridina, un procedimento per la loro preparazione e composizioni terapeutiche che li contengono.
IT1219695B (it) Derivati ad azione batteriostatica e antitossige loro preparazione e composizioni farmaceutiche
ITMI913512A1 (it) Derivati dell'eserolina ad attivita' anticolinesterasica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
0001 Granted